Context During the past 2 decades, a major transition in the clinical characterization of
psychotic disorders has occurred. The construct of a clinical high-risk (HR) state for …

These updated guidelines from the British Association for Psychopharmacology replace the
original version published in 2011. They address the scope and targets of pharmacological …

Context A substantial proportion of people at clinical high risk of psychosis will develop a
psychotic disorder over time. However, the risk of transition to psychosis varies between …

Context Indicated prevention is currently regarded as the most promising strategy to
attenuate, delay, or even avert psychosis. Existing criteria need improvement in terms of …

These guidelines from the British Association for Psychopharmacology address the scope
and targets of pharmacological treatment for schizophrenia. A consensus meeting, involving …

Abstract Treatment and prevention studies over the past decade have enrolled patients
believed to be at risk for future psychosis. These patients were considered at risk for …

Objective: Studies conducted in community samples suggest that psychotic-like experiences
are common in the general population, leading to suggestions that they are either variations …

OBJECTIVES: In early stage psychosis research the identification of neurobiological
correlates of vulnerability to schizophrenia is an important hurdle. METHODS: We …

Introduction: Prevention of psychosis has become a major objective of modern clinical
psychiatry. An increasing number of new services have been established in Europe and in …

BackgroundClinical equipoise regarding preventative treatments for psychosis has
encouraged the development and evaluation of psychosocial treatments, such as cognitive …